Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 1/20 | 0.65 |
| ▸ | PTPN1 | P18031 | 4/20 | 0.56 |
| ▸ | SOAT2 | O75908 | 1/20 | 0.52 |
| ▸ | PDE4D | Q08499 | 6/20 | 0.50 |
| ▸ | BCHE | P06276 | 5/20 | 0.49 |
| ▸ | ACHE | P22303 | 4/20 | 0.49 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.49 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.49 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.49 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.49 |
| ▸ | BACE1 | P56817 | 1/20 | 0.49 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.49 |
| ▸ | XDH | P47989 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | IDO1 | P14902 | 2/20 | 0.45 |
| ▸ | PDE2A | O00408 | 1/20 | 0.45 |
| ▸ | PDE5A | O76074 | 1/20 | 0.45 |
| ▸ | PDE9A | O76083 | 1/20 | 0.45 |
| ▸ | PDE1B | Q01064 | 1/20 | 0.45 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29377602 | 0.89 | TYR (0.53) | TYRPTPN1SOAT2PDE4DBCHE | |
| SCHEMBL31090510 | 0.79 | TYR (1.00) | TYRPTPN1SOAT2PTGS2XDH | |
| SCHEMBL30831939 | 0.79 | ADORA3 (0.53) | TYRPDE4DBCHEACHEIDO1 | |
| SCHEMBL4251925 | 0.74 | PTPN1 (0.57) | TYRPTPN1SOAT2PDE4DBCHE | |
| SCHEMBL30637452 | 0.74 | PDE4D (0.59) | PTPN1SOAT2PDE4DBCHEACHE | |
| SCHEMBL4254656 | 0.72 | PTPN1 (0.56) | TYRPTPN1SOAT2PDE4DBCHE | |
| SCHEMBL29572212 | 0.72 | ESR1 (0.56) | TYRPTPN1SOAT2PDE4DBCHE | |
| Sesalin SCHEMBL8993385 | 0.72 | PDE4D (0.63) | PTPN1PDE4D | |
| Sesalin SCHEMBL29402981 | 0.72 | PDE4D (0.63) | PTPN1PDE4D | |
| SCHEMBL24728286 | 0.72 | PDE4D (0.50) | PTPN1PDE4DXDHLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230012268-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF INFLAMMATION WITH STEROIDS AND A MODULATOR | BUZZELET DEVELOPMENT AND TECHNOLOGIES LTD (IL) | 2023-01-12 | — | — | US | claimed |
| EP-4072558-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF INFLAMMATION WITH STEROIDS AND A MODULATOR | Buzzelet Development And Technologies Ltd (IL) | 2022-10-19 | — | — | EP | claimed |
| US-20240344028-A1 | Serum-free media for producing adipocytes for animal consumption | Mosa Meat B.V. (NL) | 2024-10-17 | — | — | US | disclosed |
| US-12102653-B2 | Ligand regulated protein-protein interaction system | ST. ANNA KINDERKREBSFORSCHUNG (AT) | 2024-10-01 | — | — | US | disclosed |
| EP-4373918-A1 | SERUM-FREE MEDIA FOR PRODUCING ADIPOCYTES FOR ANIMAL CONSUMPTION | Mosa Meat B.V. (NL) | 2024-05-29 | — | — | EP | disclosed |
| US-20240000841-A1 | LIGAND REGULATED PROTEIN-PROTEIN INTERACTION SYSTEM | ST ANNA KINDERKREBSFORSCHUNG (AT) | 2024-01-04 | — | — | US | disclosed |
| US-11844813-B2 | Ligand regulated protein-protein interaction system | ST. ANNA KINDERKREBSFORSCHUNG (AT) | 2023-12-19 | — | — | US | disclosed |
| WO-2023003471-A1 | METHOD FOR PRODUCING CULTURED FAT FOR ANIMAL CONSUMPTION. | Mosa Meat B.V. (NL) | 2023-01-26 | — | — | WO | disclosed |
| WO-2023003470-A1 | SERUM-FREE MEDIA FOR PRODUCING ADIPOCYTES FOR ANIMAL CONSUMPTION. | Mosa Meat B.V. (NL) | 2023-01-26 | — | — | WO | disclosed |
| US-20230012268-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF INFLAMMATION WITH STEROIDS AND A MODULATOR | BUZZELET DEVELOPMENT AND TECHNOLOGIES LTD (IL) | 2023-01-12 | — | — | US | disclosed |
| EP-4072558-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF INFLAMMATION WITH STEROIDS AND A MODULATOR | Buzzelet Development And Technologies Ltd (IL) | 2022-10-19 | — | — | EP | disclosed |
| US-20220041687-A1 | A GROUP OF CHIMERIC ANTIGEN RECEPTORS (CARS) | ST. ANNA KINDERKREBSFORSCHUNG (AT) | 2022-02-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220041687-A1 | A GROUP OF CHIMERIC ANTIGEN RECEPTORS (CARS) | CARS1, CD74, HAVCR2 | TYR 3799/4885PTPN1 1563/4885SOAT2 3137/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.